Olema Oncology, Inc. (OLMA) stock
OLMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/30
$7.06−0.16 (-2.22%)
Close on Nov 18, 2026Market cap $617.73MP/E –Yield –
Olema Oncology operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Olema Oncology's operating cash flow for the twelve months ending Jun 30, 2026 was -$164.74M. For fiscal 2025 it was -$146.72M. The highest annual figure on record is -$3.08M in fiscal 2019.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$146.72M | – |
| FY2024 | Dec 31, 2024 | -$104.35M | – |
| FY2023 | Dec 31, 2023 | -$83.73M | – |
| FY2022 | Dec 31, 2022 | -$82.07M | – |
| FY2021 | Dec 31, 2021 | -$50.69M | – |
| FY2020 | Dec 31, 2020 | -$19.87M | – |
| FY2019 | Dec 31, 2019 | -$3.08M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$45.90M | – |
| Q1 FY2026 | Mar 31, 2026 | -$45.99M | – |
| Q4 FY2025 | Dec 31, 2025 | -$38.33M | – |
| Q3 FY2025 | Sep 30, 2025 | -$34.53M | – |
| Q2 FY2025 | Jun 30, 2025 | -$29.88M | – |
| Q1 FY2025 | Mar 31, 2025 | -$43.98M | – |
| Q4 FY2024 | Dec 31, 2024 | -$26.28M | – |
| Q3 FY2024 | Sep 30, 2024 | -$27.02M | – |
| Q2 FY2024 | Jun 30, 2024 | -$27.56M | – |
| Q1 FY2024 | Mar 31, 2024 | -$23.50M | – |
| Q4 FY2023 | Dec 31, 2023 | -$18.48M | – |
| Q3 FY2023 | Sep 30, 2023 | -$22.74M | – |
| Q2 FY2023 | Jun 30, 2023 | -$22.12M | – |
| Q1 FY2023 | Mar 31, 2023 | -$20.39M | – |
| Q4 FY2022 | Dec 31, 2022 | -$19.71M | – |
| Q3 FY2022 | Sep 30, 2022 | -$17.99M | – |
| Q2 FY2022 | Jun 30, 2022 | -$26.46M | – |
| Q1 FY2022 | Mar 31, 2022 | -$17.90M | – |
| Q4 FY2021 | Dec 31, 2021 | -$18.60M | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.10M | – |
| Q2 FY2021 | Jun 30, 2021 | -$8.91M | – |
| Q1 FY2021 | Mar 31, 2021 | -$11.08M | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.01M | – |
| Q3 FY2020 | Sep 30, 2020 | -$7.54M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.18M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.14M | – |
See a number that looks wrong?